D-0020-2023 Class II Terminated

Recalled by AuroMedics Pharma LLC — East Windsor, NJ

Recall Details

Product Type
Drugs
Report Date
November 2, 2022
Initiation Date
September 30, 2022
Termination Date
September 18, 2024
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
11,520 units

Product Description

Fondaparinux Sodium Injection, USP, 7.5 mg per 0.6 mL, Single Dose, Prefilled Syringe, Distributed by: AuroMedics Pharma LLC 279 Princeton-Hightstown Rd. E. Windsor, NJ 08520. Made in India. NDC 55150-232-10 (carton)NDC 55150-232-00 (syringe)

Reason for Recall

Subpotent Drug: Out of specification for assay

Distribution Pattern

Nationwide in the USA

Code Information

Lot # CFN200020, EXP Nov. 2022